Semaglutide — molecular reference
Semaglutide is a synthetic 31-amino-acid GLP-1 receptor agonist with a C18 fatty-diacid side chain and an engineered DPP-4-resistant substitution. It is used in receptor binding, cAMP accumulation, and CREB reporter assays in cell lines expressing GLP-1R, as well as in pancreatic β-cell and enterocyte in-vitro models of glucose-stimulated signaling. Supplied as a sterile lyophilized powder for reconstitution in bacteriostatic water. For laboratory research use only — not for human or veterinary use.
Molecular data
- Compound name
- Semaglutide (GLP-1 Receptor Agonist)
- Also referenced as
- GLP-1
- Research classification
- Peptide Hormone & Analog
- Molecular formula
- C187H291N45O59
- Average molecular mass
- ≈ 4114 Da(published value)
- Research pathway
- Metabolic Pathway
- Physical form
- Lyophilized powder
- Storage & handling
- Store lyophilized at -20°C. Protect from light.
- Available presentations
- 10mg
- Current status
- Backordered
Fields with no verifiable source are omitted rather than estimated. Where an average mass is marked as calculated, it is derived arithmetically from the molecular formula using IUPAC standard atomic weights, not measured.
Documented assay contexts
Contexts in which this compound is used as a reference material in published in-vitro work. These describe laboratory usage, not effects in any organism.
- GLP-1 receptor signaling
- cAMP / CREB reporter assays
- Pancreatic β-cell in-vitro models
Lot documentation
| Lot | Presentation | Purity | Certificate |
|---|---|---|---|
| PH260822 | 10mg | — | Testing in progress |